Trials
Search / Trial NCT00000470

Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest

Launched by BOSTON CHILDREN'S HOSPITAL · Oct 27, 1999

Trial Information

Current as of January 15, 2025

Completed

Keywords

ClinConnect Summary

BACKGROUND:

The pediatric medical community has long been concerned about the increased incidence of cerebral dysfunction among newborns with severe cyanotic congenital heart disease. There has been concern about a great number of potential predisposing factors including the effects of hypoxemia and acidosis, trauma during cardiac catheterization, and the duration of prolonged decreased arterial oxygen saturation. Many infants undoubtedly undergo significant brain damage prior to surgery, but may be subject to further insult in the peri-operative period. The proposed trial studied circulat...

Gender

ALL

Eligibility criteria

  • Boy and girl infants, up to three months of age, with transposition of the great arteries with or without septal defect.

Trial Officials

Jane Newburger

Children's Hospital Medical Center, Cincinnati

About Boston Children's Hospital

Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials